International Telemetering Conference Proceedings / October 28-31, 1996 / Town and Country Hotel and Convention Center, San Diego, California / The Department of Defense (DoD), through a Tri-Service Program Office, is developing the Common Airborne Instrumentation System (CAIS) to promote standardization, commonality, and interoperability among aircraft test instrumentation systems. The advent of CAIS will change how the DoD test community conducts business. The CAIS program will allow aircraft test and evaluation facilities to utilize common airborne systems, ground support equipment, and technical knowledge for airborne instrumentation systems. The CAIS Toolset Software (CTS) provides the capability to generate formats and load/verify airborne memories. The CTS is primarily a software applications program hosted on an IBM compatible portable personal computer with several interface cards. The software will perform most functions without the presence of the interface cards to allow the user to develop test configurations and format loads on a desktop computer.

No description available.

No description available.

Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2016-04-25T23:51:26Z No. of bitstreams: 1 RenatoFerreiraDeAlmeidaJunior_DISSERT.pdf: 1495100 bytes, checksum: f007a8b773603ddf1cf491e66172e839 (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2016-04-28T20:17:55Z (GMT) No. of bitstreams: 1 RenatoFerreiraDeAlmeidaJunior_DISSERT.pdf: 1495100 bytes, checksum: f007a8b773603ddf1cf491e66172e839 (MD5) / Made available in DSpace on 2016-04-28T20:17:55Z (GMT). No. of bitstreams: 1 RenatoFerreiraDeAlmeidaJunior_DISSERT.pdf: 1495100 bytes, checksum: f007a8b773603ddf1cf491e66172e839 (MD5) Previous issue date: 2015-03-16 / Os v?rus dengue pertence ? fam?lia Flaviviridae e ao g?nero Flavivirus, sendo composto por 4 sorotipos antigenicamente distintos, s?o considerados os arbov?rus mais importantes no mundo por causar altas taxas de morbidade e mortalidade em regi?es tropicais e subtropicais do planeta, colocando em risco at? 3,6 bilh?es de pessoas em mais de 100 pa?ses. Por ser uma doen?a com amplo espectro cl?nico e por n?o possuir vacina ou tratamento eficaz, o estudo de poss?veis antivirais que visam diminuir a viremia do paciente ? de suma import?ncia, j? que este ? um dos fatores que pode levar a febre hemorr?gica da dengue e a s?ndrome do choque da dengue que s?o as formas grave da doen?a. No presente estudo foi avaliado o potencial antiviral do extrato da folhada planta Caesalpinia echinata contra o v?rus dengue-2 (DENV-2) em cultura de c?lulas C6/36 e Vero e a a??o antiviral da Rifampicina em c?lulas Vero. A escolha da Caesalpinia echinata se deve ao fato de que j? foi observada sua a??o antiinflamat?ria e antimal?rica, al?m de n?o ter sido encontrado nenhum trabalho que tenha avaliado seu potencial de a??o frente a v?rus. A Rifampicina foi escolhida por demonstrado a??o antiviral, principalmente contra os poxvirus, por?m poucos s?os os relatos da utiliza??o deste f?rmaco contra v?rus de RNA. O resultado foi obtido atrav?s da quantifica??o da carga viral pela t?cnica da qRT-PCR em Tempo Real. As c?lulas infectadas por DENV-2 foram submetidas ao tratamento pelo per?odo de 7 dias em diferentes concentra??es do extrato da planta Caesalpinia echinataque variou entre 0,68 a 0,0068mg/mL. N?o foi poss?vel observar neste estudo, evid?ncias de inibi??o significativa da replica??o do v?rus DENV-2 em ambas as culturas celulares. ARifampicina foi utilizada em diferentes condi??es de tratamento, no qual foi avaliado ao longo de 72 horas a carga viral produzida nas c?lulas Vero.Nas condi??es de tratamento p?s-infec??o e no ensaio virucida o f?rmaco apresentou atividade antiviral, reduzindo a taxa de replica??o em 100 vezes em rela??o ao controle. De acordo com os nossos resultados conclui-se que a Rifampicina mostrou-se eficaz no combate a infec??o do DENV-2 em cultura de c?lulas Vero. / The dengue virus belongs to the Flaviviridae family and the Flavivirus genus, consisting of four serotypes antigenically distinct, are considered the most important arbovirus in the world to cause high rates of morbidity and mortality in tropical and subtropical regions of the world, threatening to 3, 6 billion people in over 100 countries. Because it is a disease with a wide clinical spectrum and has no vaccine or effective treatment, the study of possible antiviral drugs aimed at reducing viremia of patients is of paramount importance, since this is one of the factors which can lead to dengue hemorrhagic fever and dengue shock syndrome that are severe forms of the disease. In the present study we evaluated the antiviral potential of the leaf extract of the plant Caesalpinia echinata against dengue-2 virus (DENV-2) in cultured C6/36 and Vero cells and the antiviral action of Rifampicin on Vero cells. The choice of Caesalpinia echinata is due to the fact that has been observed its action anti-inflammatory and antimalarial , and not have been found no study evaluated its antiviral effect. Rifampin was chosen was chosen for demonstrated antiviral action, especially against poxviruses, but few sane reports usage of this drug against RNA viruses. The result was obtained by quantifying the viral load bythe technique of Real-time qRT-PCR. Cells infected with DENV-2 were subjected to treatment for 7 days in different concentrations of plant extract Caesalpinia echinata (0.68 - 0,0068mg / ml). As a result, we could not observe a inhibition significant of virus replication in both cell cultures. The Rifampicin was used for different treatment condition,which were evaluated over 72 hours the amount of viral load produced in Vero cells, In the conditions treatment and the test virucidal theantiviral activity, which is capable of reducing the rate of 100X replication as compared to control. According to our results we can conclude that Rifampicin was effective in action against to infection DENV-2 in Vero cell culture.

Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2016-04-25T23:51:26Z No. of bitstreams: 1 TabataLoiseCunhaLima_DISSERT.pdf: 1403767 bytes, checksum: 7424c70f286f04743b45ac7531e6829b (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2016-04-28T20:23:59Z (GMT) No. of bitstreams: 1 TabataLoiseCunhaLima_DISSERT.pdf: 1403767 bytes, checksum: 7424c70f286f04743b45ac7531e6829b (MD5) / Made available in DSpace on 2016-04-28T20:23:59Z (GMT). No. of bitstreams: 1 TabataLoiseCunhaLima_DISSERT.pdf: 1403767 bytes, checksum: 7424c70f286f04743b45ac7531e6829b (MD5) Previous issue date: 2015-03-13 / A dengue ? uma doen?a de notifica??o compuls?ria e cerca de 50 a 100 milh?es de casos s?o registrados anualmente. Possui amplo espectro cl?nico e ? transmitida ao homem atrav?s da picada dos mosquitos do g?nero Aedes, tendo como principal vetor a esp?cie Aedes aegypti. O agente etiol?gico da doen?a ? o v?rus dengue (DENV) pertencente ao g?nero Flavivirus, fam?lia Flaviviridae e s?o conhecidos quatro sorotipos antigenicamente distintos (DENV-1, DENV-2, DENV-3 e DENV-4). Atualmente o tratamento da dengue ? apenas de suporte, feito atrav?s de intensa hidrata??o. Ainda n?o existe uma vacina comprovadamente eficaz ou tratamento espec?fico, o estudo de poss?veis antivirais que possam diminuir a viremia no paciente ? de alt?ssima relev?ncia, uma vez que a carga viral ? um dos fatores associado ao aparecimento das formas graves da doen?a (febre hemorr?gica da dengue e s?ndrome do choque da dengue). No presente estudo n?s avaliamos o potencial antiviral de extratos brutos obtidos a partir das folhas das plantas do Nordeste brasileiro Annona muricata (graviola) e Spondias mombin (caj?) contra o DENV-2 em cultura de c?lulas C6/36 e Vero. A avalia??o da a??o dos extratos brutos foi feita por meio da quantifica??o da carga viral atrav?s da PCR em Tempo Real (qRT-PCR) e pela t?cnica de contagem de unidades formadoras de placa (PFU). As concentra??es dos extratos de ambas as plantas utilizadas foram: 0,01, 0,1 e 1mg/mL. As culturas de c?lulas infectadas foram submetidas ao tratamento com os extratos durante os per?odos de 24-168h horas (7 dias). C?lulas Vero tratadas com o extrato da S. mombin n?o apresentaram redu??o na carga viral. Em contrapartida, quando estas c?lulas foram tratadas com o extrato da A. muricata, uma hora ap?s infec??o, observou-se uma redu??o significativa na carga viral nas primeiras horas (24h), quando comparadas com as c?lulas n?o tratadas utilizadas como controle positivo. Ao serem tratadas em intervalos de 24 horas apresentaram uma redu??o na carga viral nos dias subsequentes (at? o s?timo dia). N?o foi observada redu??o na carga viral em c?lulas C6/36 tratadas com ambos os extratos. De acordo com os nossos resultados, o extrato da planta A. muricata possui potencial antiviral promissor contra a infec??o pelo DENV-2 em cultura de c?lulas Vero. / Dengue is a reportable disease and about 50 to 100 million cases are reported annually. It has a wide clinical spectrum and is transmitted to humans through the bite of Aedes mosquitos, the main vector the Aedes aegypti species. The causative agent of disease is dengue virus (DENV) belonging to the genus Flavivirus, family Flaviviridae and are known four antigenically distinct serotypes (DENV-1, DENV-2, DENV-3 and DENV-4). Currently the treatment of dengue is supportive, made by intense hydration. Although there is no proven effective vaccine or specific treatment, the study of potential antiviral drugs that can reduce viremia in patients is very high importance, since the viral load is one of the factors associated with the development of severe forms of the disease (hemorrhagic fever dengue and dengue shock syndrome). In the present study we evaluated the antiviral potential of crude extracts obtained from the leaves of plants in Northeastern Brazil Annona muricata (soursop) and Spondias mombin (caja) against DENV-2 in cultured C6/36 and Vero. The evaluation of the activity of the crude extracts was performed by the quantification of viral load by RT-PCR (qRT-PCR) and counting technique of plaque forming units (PFU). The concentrations of extracts of both plants used were 0.01, 0.1 and 1 mg/mL. The infected cell cultures were subjected to treatment with the extracts during periods of 24-168h hours (7 days). Vero cells treated with the S. mombin extract showed no reduction in viral load. In contrast, when these cells were treated with the extract of A. muricata, one hour after infection, significant reductions in viral load in the first hour was observed (24 h) when compared to untreated cells used as positive control. When they are treated at 24 hour intervals showed a reduction in viral load in subsequent days (until day). There was no reduction in viral load in C6/36 cells treated with both extracts. According to our results, the plant extract has antiviral A. muricata promising potential against infection by DENV-2 in Vero cell culture.